Boundless Bio, Common Stock Market Value
| BOLD Stock | USD 2.59 0.07 2.78% |
| Symbol | Boundless |
Boundless Bio, Common Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Return On Assets (0.24) | Return On Equity (0.36) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Boundless Bio, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Boundless Bio,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Boundless Bio,.
| 11/22/2024 |
| 12/22/2024 |
If you would invest 0.00 in Boundless Bio, on November 22, 2024 and sell it all today you would earn a total of 0.00 from holding Boundless Bio, Common or generate 0.0% return on investment in Boundless Bio, over 30 days. Boundless Bio, is related to or competes with Supercom, Jacobs Solutions, Playtika Holding, Sabre Corpo, Enersys, Reservoir Media, and Emerson Radio. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene ther... More
Boundless Bio, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Boundless Bio,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Boundless Bio, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 28.03 | |||
| Value At Risk | (10.03) | |||
| Potential Upside | 8.77 |
Boundless Bio, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boundless Bio,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Boundless Bio,'s standard deviation. In reality, there are many statistical measures that can use Boundless Bio, historical prices to predict the future Boundless Bio,'s volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.47) |
Boundless Bio, Common Backtested Returns
Boundless Bio, Common secures Sharpe Ratio (or Efficiency) of -0.0794, which signifies that the company had a -0.0794% return per unit of risk over the last 3 months. Boundless Bio, Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Boundless Bio,'s Mean Deviation of 4.05, risk adjusted performance of (0.08), and Standard Deviation of 5.5 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.3, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Boundless Bio, will likely underperform. At this point, Boundless Bio, Common has a negative expected return of -0.41%. Please make sure to confirm Boundless Bio,'s accumulation distribution, and the relationship between the potential upside and day median price , to decide if Boundless Bio, Common performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.41 |
Modest reverse predictability
Boundless Bio, Common has modest reverse predictability. Overlapping area represents the amount of predictability between Boundless Bio, time series from 22nd of November 2024 to 7th of December 2024 and 7th of December 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Boundless Bio, Common price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Boundless Bio, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.41 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Boundless Bio, Common lagged returns against current returns
Autocorrelation, which is Boundless Bio, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Boundless Bio,'s stock expected returns. We can calculate the autocorrelation of Boundless Bio, returns to help us make a trade decision. For example, suppose you find that Boundless Bio, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Boundless Bio, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Boundless Bio, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Boundless Bio, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Boundless Bio, stock over time.
Current vs Lagged Prices |
| Timeline |
Boundless Bio, Lagged Returns
When evaluating Boundless Bio,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Boundless Bio, stock have on its future price. Boundless Bio, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Boundless Bio, autocorrelation shows the relationship between Boundless Bio, stock current value and its past values and can show if there is a momentum factor associated with investing in Boundless Bio, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Boundless Bio, Common is a strong investment it is important to analyze Boundless Bio,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio,'s future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports:Check out Boundless Bio, Correlation, Boundless Bio, Volatility and Boundless Bio, Alpha and Beta module to complement your research on Boundless Bio,. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Boundless Bio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.